Coagulation factors are protein components of the blood which serve blood coagulation.
Search results 76 to 87 from a total of 87
| Name | Marketing Authorisation Holder | License Number | License Date | Further Information |
|---|---|---|---|---|
IMMUNINE 600 I.E. |
Takeda GmbH |
PEI.H.03595.02.1 | 05.05.2008 | |
|
IMMUNATE 500 I.E. |
Takeda GmbH |
3854.02.00 | 20.10.1983 | |
|
IMMUNATE 1000 I.E. |
Takeda GmbH |
3854.03.00 | 20.10.1983 | |
|
Immuseven |
Takeda GmbH |
PEI.H.03341.01.1 | 28.11.2005 | |
Recombinate Antihaemophilie Faktor (rekombinant) 1000 |
Takeda GmbH |
28530.02.00 | 30.07.1993 | |
ADVATE |
Takeda Manufacturing Austria AG |
EU/1/03/271 | 02.03.2004 | |
Beriate 2000 |
Orifarm GmbH |
PEI.H.12092.02.1 | 19.04.2021 | |
Octanate 1000 |
CC-Pharma GmbH |
PEI.H.12112.01.1 | 05.07.2021 | |
Beriate 1000 |
CC-Pharma GmbH |
PEI.H.12077.02.1 | 06.05.2021 | |
IMMUNINE 1200 I.E. |
Orifarm GmbH |
PEI.H.12094.01.1 | 24.03.2021 | |
Beriate 2000 |
CC-Pharma GmbH |
PEI.H.12077.01.1 | 10.03.2021 | |
Haemate P 1000 I.E. FVIII / 2400 I.E. VWF |
Orifarm GmbH |
PEI.H.12082.01.1 | 24.03.2021 |
The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.
The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.
As of: PEI announcement No. 530 in BAnz AT 16.06.2025 B4.
Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.
If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.
Updated: 17.06.2025
